| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |